DD149366A5 - Verfahren zur herstellung von penicillansaeure-derivaten - Google Patents

Verfahren zur herstellung von penicillansaeure-derivaten Download PDF

Info

Publication number
DD149366A5
DD149366A5 DD80219434A DD21943480A DD149366A5 DD 149366 A5 DD149366 A5 DD 149366A5 DD 80219434 A DD80219434 A DD 80219434A DD 21943480 A DD21943480 A DD 21943480A DD 149366 A5 DD149366 A5 DD 149366A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
ester
carbon atoms
beta
added
Prior art date
Application number
DD80219434A
Other languages
German (de)
English (en)
Inventor
Michael S Kellogg
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD149366A5 publication Critical patent/DD149366A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD80219434A 1979-03-05 1980-03-04 Verfahren zur herstellung von penicillansaeure-derivaten DD149366A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1780979A 1979-03-05 1979-03-05
US06/096,832 US4397783A (en) 1979-03-05 1979-11-23 Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners

Publications (1)

Publication Number Publication Date
DD149366A5 true DD149366A5 (de) 1981-07-08

Family

ID=26690341

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80219434A DD149366A5 (de) 1979-03-05 1980-03-04 Verfahren zur herstellung von penicillansaeure-derivaten

Country Status (29)

Country Link
US (1) US4397783A (ko)
KR (1) KR840000589B1 (ko)
AR (1) AR225758A1 (ko)
AT (1) AT369744B (ko)
AU (1) AU518472B2 (ko)
CA (1) CA1154011A (ko)
CH (1) CH648850A5 (ko)
DD (1) DD149366A5 (ko)
DE (1) DE3008316C2 (ko)
DK (1) DK157136C (ko)
ES (1) ES8103095A1 (ko)
FI (1) FI71739C (ko)
FR (1) FR2450837A1 (ko)
GB (1) GB2047684B (ko)
GR (1) GR67697B (ko)
HK (1) HK66687A (ko)
IE (1) IE51931B1 (ko)
IL (1) IL59514A (ko)
IT (1) IT1130301B (ko)
KE (1) KE3456A (ko)
LU (1) LU82219A1 (ko)
MY (1) MY8500320A (ko)
NL (1) NL8001286A (ko)
NO (1) NO800617L (ko)
OA (1) OA06496A (ko)
PH (2) PH18550A (ko)
PT (1) PT70898A (ko)
SE (1) SE451329B (ko)
SG (1) SG56484G (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518530A (en) * 1979-03-05 1985-05-21 Pfizer Inc. 6-β-Substituted penicillanic acids as β-lactamase inhibitors
IE49770B1 (en) 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
GB8522156D0 (en) * 1985-09-06 1985-10-09 Leo Pharm Prod Ltd Producing chemical compounds
JPH07103129B2 (ja) * 1986-04-10 1995-11-08 レオ・ファーマシューティカル・プロダクツ・リミテッド・エイ／エス（レーベンス・ケミスケ・ファブリック・プロデュクチオンスアクチーセルスカブ） ペニシラン酸誘導体の改良された新規合成方法
PA8579701A1 (es) * 2002-08-23 2005-05-24 Pfizer Prod Inc Profarmaco inhibidor de beta-lactamasa
CA2528065A1 (en) * 2003-06-05 2004-12-16 Pfizer Products Inc. Beta-lactamase inhibitor prodrug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749555B2 (ko) * 1973-04-04 1982-10-22
US4093625A (en) * 1976-08-09 1978-06-06 Massachusetts Institute Of Technology 6-Sulfur analogs of penicillins and cephalosporins
US4180506A (en) * 1978-01-18 1979-12-25 Rex Pratt 6β-Bromo penicillanic acid
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
US4203992A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. β-Bromopenicillanic acid sulfone
IL59081A0 (en) * 1979-01-10 1980-05-30 Schering Corp 2-penem compounds and a method for preparing them
DE3068390D1 (en) * 1979-01-10 1984-08-09 Beecham Group Plc Penicillin derivatives, process for their preparation and pharmaceutical compositions containing certain of these compounds

Also Published As

Publication number Publication date
IL59514A0 (en) 1980-06-30
NO800617L (no) 1980-09-08
AR225758A1 (es) 1982-04-30
FI71739C (fi) 1987-02-09
CA1154011A (en) 1983-09-20
DK157136B (da) 1989-11-13
ES489186A0 (es) 1981-02-16
ES8103095A1 (es) 1981-02-16
SE8001689L (sv) 1980-09-06
IL59514A (en) 1984-01-31
KR830001941A (ko) 1983-05-19
GB2047684A (en) 1980-12-03
OA06496A (fr) 1981-07-31
AU518472B2 (en) 1981-10-01
NL8001286A (nl) 1980-09-09
FI800662A (fi) 1980-09-06
KR840000589B1 (ko) 1984-04-24
AT369744B (de) 1983-01-25
SG56484G (en) 1985-03-08
PH18550A (en) 1985-08-09
PT70898A (en) 1980-04-01
FR2450837A1 (fr) 1980-10-03
DE3008316A1 (de) 1980-09-25
MY8500320A (en) 1985-12-31
DK92880A (da) 1980-09-06
PH17879A (en) 1985-01-14
IT8020368A0 (it) 1980-03-05
US4397783A (en) 1983-08-09
IE800428L (en) 1980-09-05
SE451329B (sv) 1987-09-28
DK157136C (da) 1990-04-16
HK66687A (en) 1987-09-25
GB2047684B (en) 1983-09-28
IT1130301B (it) 1986-06-11
DE3008316C2 (de) 1982-12-16
LU82219A1 (fr) 1980-09-24
AU5610580A (en) 1980-09-18
FI71739B (fi) 1986-10-31
IE51931B1 (en) 1987-04-29
ATA118980A (de) 1982-06-15
KE3456A (en) 1984-10-12
GR67697B (ko) 1981-09-07
FR2450837B1 (ko) 1984-01-13
CH648850A5 (de) 1985-04-15

Similar Documents

Publication Publication Date Title
DE3039504C2 (de) Derivate von 6β-Hydroxyalkylpenicillansäuren und solche Derivate enthaltende Arzneimittel
DE2824535C3 (de) Penicillansäure-l,l-dioxide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4276285A (en) Combinations of penicillanic acid 1,1-dioxide with 7-(D-2-[4-ethylpiperazin-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-desacetoxymethylcephalosporanic acid
DD149366A5 (de) Verfahren zur herstellung von penicillansaeure-derivaten
DE2324272A1 (de) 3-methylencephalosporine
CA1150242A (en) ACETOXYMETHYL PENAM COMPOUNDS AS .beta.-LACTAMASE INHIBITORS
JPH0342277B2 (ko)
DE3008257A1 (de) Verfahren zur herstellung von penicillansaeure-1,1-dioxid und dessen estern sowie zwischenstufen zur durchfuehrung des verfahrens
US4656263A (en) 6-β-substituted penicillanic acid compound free of the 6-α-epimer
DD234015A5 (de) Verfahren zur herstellung von 6-(subst.)-methylen-penicillan-und 6-(subst.)-hydroxymethyl-penicillansaeure und deren derivaten
DE3833693A1 (de) Stabile oxapenem-3-carbonsaeuren und ihre verwendung als ss-lactamasehemmer
DE4037841A1 (de) Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4518530A (en) 6-β-Substituted penicillanic acids as β-lactamase inhibitors
DD218365A5 (de) Verfahren zur herstellung von 6-aminomethylpenicillansaeure-1,1-dioxid-derivaten als beta-lactamase-inhibitoren
DE2336344A1 (de) Penicillin- und cephalosporin-rsulfoxide, ihre salze und ester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2454109A1 (de) Neue cephalosporinderivate, deren herstellung und diese enthaltende zusammensetzungen
US4517126A (en) Penicillanic acid derivative
DE4027928A1 (de) Neue 2-tert.substituierte methyl-oxapenem-3-carbonsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung
DD258020A5 (de) Verfahren zur herstellung von penicillansaeurederivaten
CH556876A (de) Verfahren zur herstellung von cephalosporansaeurederivaten.
EP0007717A1 (en) Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them
DD146790A6 (de) Verfahren zur verstaerkung der antibakteriellen wirksamkeit einer 7-(d-2-eckige klammer auf 4-aethylpiperazin-2,3-dion-1-carboxamido eckige klammer zu-2-eckige klammer auf 4-hydroxyphenyl eckige klammer zu acetamido)-3-(eckige klammer auf 1-methyl-5-tetrazolyl eckige klammer zu-thiomethyl)-3-desacetoxymethylcephalosphoransaeure
DD146603A5 (de) Verfahren zur herstellung neuer 7 alpha-methoxycephalosporine
NO801977L (no) Fremgangsmaate for fremstilling av klavulansyrederivater